Traws Pharma
TRAW
TRAW
27 hedge funds and large institutions have $1.29M invested in Traws Pharma in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less capital invested
Capital invested by funds: $1.73M → $1.29M (-$442K)
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$467K | |
| 2 | +$43.9K | |
| 3 | +$37.6K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$14K |
| 5 |
VF
Virtu Financial
New York
|
+$12K |
Top Sellers
| 1 | -$73.8K | |
| 2 | -$38.4K | |
| 3 | -$22.4K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.01K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$759 |